The world's political record
Records whose title is actually about this topic. Use a country filter if the list is still too broad.
501 records in US in 2018
United States · United States Congress · 15 May 2018
Postoperative Opioid Prevention Act of 2018 This bill temporarily increases payment under Medicare for certain non-opioid analgesics that are used for pain management in hospital outpatient department services.
United States · United States Congress · 15 May 2018
Post-Surgical Injections as an Opioid Alternative Act This bill temporarily freezes Medicare payment at 2016 levels for specified spinal surgery outpatient procedures that are conducted in ambulatory surgical centers.
United States · United States Congress · 15 May 2018
Medicaid Institutes for Mental Disease Are Decisive in Delivering Inpatient Treatment for Individuals but Opportunities for Needed Access are Limited without Information Needed about Facility Obligations Act or the Medicaid IMD ADDITIONAL INFO Act This bill requires the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission to report on information relating to services for Medicaid enrollees who are patients in institutions for mental diseases (IMDs), including: (1) the number and type of IMDs in each sampled state and associated coverage limitations, (2) services and processes provided at such IMDs, (3) applicable federal waivers and other Medicaid funding sources for such IMDs, (4) state requirements for such IMDs to receive funding, and (5) recommendations to improve standards and data collection for IMDs.
United States · United States Congress · 15 May 2018
Medicaid Health Homes for Opioid-Use-Disorder Medicaid Enrollees Encouraged Act or the Medicaid Health HOME Act This bill extends the enhanced federal matching rate for expenditures regarding substance-use disorder health-home services under Medicaid.
United States · United States Congress · 15 May 2018
Medicaid Pharmaceutical Home Act of 2018 This bill requires state Medicaid programs to establish drug-management programs for at-risk beneficiaries (those identified as at risk of abusing or misusing controlled substances).
United States · United States Congress · 15 May 2018
Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions.
United States · United States Congress · 15 May 2018
Opioid Screening and Chronic Pain Management Alternatives for Seniors Act This bill requires the initial examination for new Medicare enrollees to include a review of current opioid prescriptions and an opioid use disorder screening.
United States · United States Congress · 15 May 2018
Overdose Prevention and Patient Safety Act This bill aligns federal privacy standards for substance use disorder patient records more closely with standards under the Health Insurance Portability and Accountability Act, including authorized disclosures and penalty structures for violations.
United States · United States Congress · 15 May 2018
This bill allows states to receive federal payment under Medicaid for outside services that are provided to pregnant and postpartum women who are substance use disorder patients at institutions for mental diseases. State Medicaid programs may also cover residential pediatric recovery center services for infants with neonatal abstinence syndrome.
United States · United States Congress · 15 May 2018
This bill specifies that the Center for Medicare and Medicaid Innovation may test models to: (1) help individuals learn about the availability of psychologist services under Medicare, and (2) explore the use of a behavioral health help-line that is available 24-7 to prevent unnecessary hospitalizations and emergency department visits through treatment education. The Government Accountability Office must report on the availability of behavioral health services under Medicare.
United States · United States Congress · 15 May 2018
21st Century Tools for Pain and Addiction Treatment Act This bill requires the Food and Drug Administration (FDA) to revise how it will address the challenges and barriers of developing non-addictive medical products to treat pain or addiction.
United States · United States Congress · 15 May 2018
Disaster Preparedness for Power Outages Act of 2018 This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to award grants to long-term care facilities to help such facilities prepare for power outages during and after natural disasters. Eligible grant activities include the purchase of backup power sources (e.g., generators) and the creation of regional resource directories.
United States · United States Congress · 15 May 2018
Opioid Workforce Act of 2018 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period.
United States · United States Congress · 15 May 2018
Saving American Families through Efficacy and Trusted Ways Act of 2018 or the SAFETY Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to refuse or withdraw approval for a new drug application if the drug is unsafe due to the risk of abuse or misuse.
United States · United States Congress · 15 May 2018
Ensuring Complete Coverage of Medication-Assisted Treatment Act This bill requires coverage of medication-assisted treatment, which is used to treat substance-use disorders, under Medicaid.
United States · United States Congress · 15 May 2018
Comprehensive TB Elimination Act of 2018 This bill amends the Public Health Service Act to reauthorize for FY2018-FY2023 and revise the tuberculosis (TB) prevention and treatment grant program administered by the Centers for Disease Control and Prevention. The Health Resources and Services Administration may also award grants to state and local governments and federally-qualified health centers for TB prevention and treatment efforts. Additionally, the Government Accountability Office must report on national TB prevention and treatment efforts.
United States · United States Congress · 15 May 2018
Regional Health Care Emergency Preparedness and Response Systems Act This bill requires the Office of the Assistant Secretary for Preparedness and Response (ASPR) to publish guidelines for health care facilities on responding to a public health emergency involving chemical, biological, radiological, or nuclear agents. ASPR may also establish a demonstration program to improve medical response systems in accordance with the guidelines. The Government Accountability Office must report on the progress of health care facilities in implementing the guidelines.
United States · United States Congress · 15 May 2018
Opioid Workforce Act of 2018 This bill increases the number of residency positions eligible for graduate medical education payments under Medicare for hospitals that have addiction or pain management programs, with an aggregate increase of 1,000 positions over a five-year period.
United States · United States Congress · 15 May 2018
Supports the designation, and the goals and ideals, of May 2018 as National Bladder Cancer Awareness Month. Calls on the people of the United States, interested groups, and affected persons to: (1) promote awareness of bladder cancer and to foster understanding of the impact of the disease on patients and their families and caregivers, and (2) take an active role in the fight to end bladder cancer.
United States · United States Congress · 15 May 2018
Expresses support for the goals of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) International Awareness Day. Encourages the National Institutes of Health and other federal agencies to work with experts, stakeholders, and individuals with ME/CFS to support research to discover the cause of, and a cure for, ME/CFS.
United States · United States Congress · 15 May 2018
Expresses support for: (1) the goals and ideals of National Women's Health Week to empower young women to make informed choices about their sexual activity and to take effective steps to protect against human immunodeficiency virus (HIV); and (2) the investment of the President's Emergency Plan for AIDS Relief in the Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe partnership, which aims to reduce new HIV infections among adolescent girls and young women.
United States · United States Congress · 11 May 2018
Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018 This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period). The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs. The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.
United States · United States Congress · 11 May 2018
Combating Opioid Abuse for Care in Hospitals Act of 2018 or the COACH Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to: (1) publish guidance for hospitals on pain management and opioid-use disorder prevention strategies for Medicare beneficiaries, (2) convene a technical expert panel to recommend opioid and opioid-use disorder quality measures for possible use in hospital payment and reporting models under Medicare, and (3) publish and periodically update all guidance issued since January 1, 2016, related to the prescription of opioids for Medicare beneficiaries. Additionally, the Department of Health and Human Services must: (1) convene a technical expert panel to recommend ways to reduce opioid use in surgical settings and best practices for pain management, specifically during the perioperative (pre-operative through post-operative) period; and (2) report on diagnosis-related group codes that have the highest volume of surgeries and the availability of associated data regarding post-operative opioid use, including prescription patterns and rates of consumption.
United States · United States Congress · 11 May 2018
Preventing Addiction for Susceptible Seniors Act of 2018 or the PASS Act of 2018 This bill alters several requirements under the Medicare prescription drug benefit. Specifically, the bill: (1) requires prescription drug plan sponsors to establish drug management programs for at-risk beneficiaries; (2) requires electronic prescription programs to enable the secure transmittal of prior authorization requests for covered drugs; and (3) establishes individuals who are identified as at-risk beneficiaries for prescription drug abuse as qualifying participants in medication therapy management programs. The bill also requires the Centers for Medicare & Medicaid Services (CMS) to establish a secure online portal to allow: (1) data sharing among the CMS, Medicare prescription drug benefit plans, and Medicare Advantage (MA) plans; and (2) referrals by such plans of substantiated fraud, waste, or abuse in order to initiate or assist investigations by contracted entities under the Medicare Integrity Program. The CMS must also: (1) identify outlier prescribers of opioids under Medicare prescription drug benefit plans and MA plans, based on specialty and geographic area; and (2) annually notify such prescribers of their status and provide them with resources on proper prescribing methods.
United States · United States Congress · 11 May 2018
Medicare and Opioid Safe Treatment Act or the MOST Act This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage, related to pain management and opioid use. For example, the bill requires certified opioid treatment program services to be covered under Medicare. Additionally, among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly. The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).
United States · United States Congress · 11 May 2018
Opioid Crisis Accountability Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks, supplying states or communities with a quantity of opioids that is not medically necessary, or failing to report any order or pattern of orders that would cause a reasonable person to believe the opioids were not being dispensed in a medically reasonable manner.
United States · United States Congress · 11 May 2018
Promoting Quality of Care in Pain Management Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to convene a technical expert panel to recommend opioid and opioid-use disorder quality measures for possible use in hospital payment and reporting models under Medicare.
United States · United States Congress · 11 May 2018
Promoting Outpatient Access to Non-Opioid Treatments Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly.
United States · United States Congress · 11 May 2018
Centralized Opioid Guidance Act of 2018 or the COG Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to publish and periodically update all guidance issued since January 1, 2016, related to the prescription of opioids for Medicare beneficiaries.
United States · United States Congress · 11 May 2018
Jobs and Justice Act of 2018 This bill addresses a wide variety of domestic policy matters and focuses on economically distressed communities, opportunities for minorities and the disadvantaged, and civil rights enforcement. Included in the programs and requirements affected are those concerning: diversity in contracting; infrastructure development; areas of persistent poverty; job training for youth and older Americans; education of girls and minorities in STEM fields; the federal minimum wage; military family benefits; health care coverage and access; small business investment; commercial investment in underserved areas, including through tax benefits; housing, including affordability and homelessness programs, landlord-tenant matters, public housing, foreclosure mitigation, and discrimination; access to higher education, including through community college attendance; science, technology, and information security education; hate crimes; law enforcement officer conduct; law enforcement resources and administration; juvenile justice; sentencing procedures; voting rights and administration; prison administration; and firearms sales and possession.
United States · United States Congress · 10 May 2018
Stop Illicit Drug Importation Act of 2018 This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to prohibit the importation of certain drugs or destroy illegally imported or hazardous drugs.
United States · United States Congress · 10 May 2018
Easy Medication Access and Treatment for Opioid Addiction Act or the Easy MAT for Opioid Addiction Act This bill requires the Drug Enforcement Administration to revise regulations to allow the administration of up to a three-day supply of narcotic drugs to an individual at one time for purposes of relieving acute withdrawal symptoms while the individual awaits arrangements for narcotic treatment. Current regulations authorize up to a one-day supply of narcotic drugs for an individual at one time and for a total of up to three days.
United States · United States Congress · 10 May 2018
Expanding Access to Treatment Act This bill requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment. Specifically, a federally qualified health center or rural health clinic may receive payment for each health care practitioner who becomes certified on or after January 1, 2019, to prescribe or dispense methadone, buprenorphine, or suboxone (medications used to treat opioid-use disorders). The Centers for Medicare & Medicaid Services must set payments based on training costs for practitioner certification.
United States · United States Congress · 10 May 2018
Expanding Access to Diabetes Self-Management Training Act of 2018 or the Expanding Access to DSMT Act of 2018 This bill expands Medicare coverage of diabetes outpatient self-management training, and establishes a demonstration program to test an online platform that provides such training.
United States · United States Congress · 10 May 2018
Fighting Medicare Fraud Act of 2018 This bill expands the authority of the Centers for Medicare & Medicaid Services (CMS) to exclude from participation in federal health programs certain affiliates of a sanctioned entity. (A "sanctioned entity" is one that has been convicted of one of several specified crimes or excluded from participation under either Medicare or a state health care program.) In addition, the bill requires Medicare Advantage organizations to report instances of fraud or abuse to the CMS within 60 days.
United States · United States Congress · 10 May 2018
Ending Maternal Mortality Act of 2018 This bill amends the Public Health Service Act to require the Department of Health and Human Services to publish every two years a national plan to reduce the rate of preventable maternal mortality (maternal deaths that occur during or within 12 months of pregnancy). Each plan must address specific issues relating to maternal mortality and severe maternal morbidity (unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health), such as issues surrounding public awareness, at-risk populations and disparities, and quality of care.
United States · United States Congress · 10 May 2018
Supports the designation of National Lyme Disease Awareness Month to increase public knowledge of the disease, raise awareness about the prevention of tick bites, and advance the vision of finding a cure through critical research.
United States · United States Congress · 10 May 2018
Supporting and Improving Rural EMS Needs Act of 2018 or the SIREN Act of 2018 This bill reauthorizes through FY2023 and revises the Rural Emergency Medical Service Training and Equipment Assistance Program, which is administered by the Health Resources and Services Administration.
United States · United States Congress · 10 May 2018
Sober Home Fraud Detection Act This bill requires the Department of Health and Human Services to publish common indicators of potentially fraudulent or disreputable recovery housing (alcohol- and drug-free shared living environments that promote recovery from substance use disorders), such as with respect to unusual billing practices, longer than average occupancies, and excessive levels of drug testing.
United States · United States Congress · 10 May 2018
Mark Takai Atomic Veterans Healthcare Parity Act This bill includes veterans who participated in the cleanup of Enewetak Atoll in the Marshall Islands anytime from 1977 through 1980 as radiation exposed veterans for purposes of the Department of Veterans Affairs presumption of service-connection for specified cancers. These veterans thereby become eligible for the same health care and other benefits given to service members who were involved in active nuclear tests. Under a presumption of service-connection, specific disabilities diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded.
United States · United States Congress · 9 May 2018
Expanding Oversight of Opioid Prescribing and Payment Act of 2018 This bill requires the Medicare Payment Advisory Commission to report to Congress on: (1) how Medicare pays for opioid and non-opioid pain management treatments in inpatient and outpatient hospital settings; (2) current incentives for prescribing opioid and non-opioid treatments under Medicare inpatient and outpatient prospective payment systems, along with recommendations to address any identified adverse incentives; and (3) how opioid use is currently tracked and monitored through Medicare and any areas for improvement.
United States · United States Congress · 9 May 2018
Commit to Opioid Medical Prescriber Accountability and Safety for Seniors Act or the COMPASS Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to identify outlier prescribers of opioids under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans. Specifically, the CMS must: (1) establish an opioid-prescription threshold for determining whether a prescriber is an outlier compared to other prescribers, based on specialty and geographic area; (2) use National Provider Identifiers (unique provider identification numbers currently included on claims for covered drugs) to identify outlier prescribers; and (3) annually notify identified outlier prescribers of their status and provide them with resources on proper prescribing methods. The CMS may also identify and notify outlier prescribers based on co-prescriptions of covered drugs that have adverse effects when used in combination with opioids.
United States · United States Congress · 9 May 2018
Strengthening Partnerships to Prevent Opioid Abuse Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish a secure online portal to allow: (1) data sharing among the CMS, Medicare prescription drug benefit plans, and Medicare Advantage (MA) plans; and (2) referrals by such plans of substantiated fraud, waste, or abuse in order to initiate or assist investigations by contracted entities under the Medicare Integrity Program. The CMS must disseminate and report certain collected information to such plans, including information regarding providers that were referred through the portal and trends in identifying suspicious activity. Additionally, for plan years beginning on or after January 1, 2021, MA organizations must submit information to the CMS regarding investigations or other actions taken by MA plans against providers that prescribe high volumes of opioids (as determined by the CMS).
United States · United States Congress · 9 May 2018
Prescription Drug and Medical Device Price Review Board Act of 2018 This bill establishes the Prescription Drug and Medical Device Price Review Board within the Food and Drug Administration. Each manufacturer of a prescription drug or medical device that is sold in the United States must submit to the board: each type of prescription drug and medical device that it sells in the United States, or in a country that is a member of the Organization for Economic Co-operation and Development; the price charged by the manufacturer for the drug or device; and the costs of the manufacturer to produce them. The board must establish a formula for determining whether the average manufacturer price of a prescription drug or medical device over an annual quarter is an excessive price. Manufacturers may not charge excessive prices. Individuals may petition the board to determine whether the price for a prescription drug or medical device is excessive. The board may subject violators to reduced patent terms, civil penalties, and increased Medicaid rebates payable to states. The bill amends the Internal Revenue Code to impose a tax on the sale of prescription drugs or medical devices that have excessive prices. The board must allow individuals to import from approved counties prescription drugs and devices that are comparable to prescription drugs and devices with excessive prices.
United States · United States Congress · 9 May 2018
Dr. Todd Graham Pain Management Improvement Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to publish a report on whether Medicare payments, coverage, and coding policies for non-opioid pain management treatments should be revised. The report must include an analysis of pain management and prescribing guidelines, access to non-opioid treatments, and the effect of any recommended changes on Medicare and enrollee opioid addiction.
United States · United States Congress · 9 May 2018
Benefit Evaluation of Safe Treatment Act of 2018 or the BEST Act of 2018 This bill requires the Centers for Medicare & Medicaid Services to report on the availability of supplemental health care benefits for the prevention and treatment of substance use disorders under Medicare Advantage (MA) plans, including differences between MA plans for certain individuals with special needs and other MA plans.
United States · United States Congress · 9 May 2018
Perioperative Reduction of Opioids Act or the PRO Act This bill requires the Department of Health and Human Services (HHS) to convene a technical expert panel to recommend ways to reduce opioid use in surgical settings and best practices for pain management, specifically during the perioperative (pre-operative through post-operative) period. HHS must also report on diagnosis-related group codes that have the highest volume of surgeries and the availability of associated data regarding post-operative opioid use, including prescription patterns and rates of consumption.
United States · United States Congress · 9 May 2018
Education for Disposal of Unused Opioids Act of 2018 or the EDU Act of 2018 This bill requires Medicare medication therapy management programs and Medicare Advantage in-home health risk assessments to include information about the safe disposal of prescription drugs.
United States · United States Congress · 9 May 2018
Reduce Overprescribing Opioids in Treatment Act of 2018 or the ROOT Act of 2018 This bill prohibits inclusion of pain management questions in a specified health care system survey used by the Centers for Medicare & Medicaid Services, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.
United States · United States Congress · 9 May 2018
Comprehensive Addiction Recovery through Effective Employment and Reentry Act or the CAREER Act This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to establish a pilot program to award grants to states in order to assist individuals with the transition from substance use disorder treatment programs to independent living and the workforce. Eligible grant activities include outpatient treatment programs, care coordination services, and vocational training. HHS may award five-year grants to up to five states (based in part on specified unemployment and overdose data) and one-year grants to states and Indian tribes (based on criteria determined by HHS). Additionally, the bill amends the Housing and Community Development Act of 1974 to include temporary housing services for individuals transitioning from substance use disorder treatment programs as qualifying activities for which states may use federal funds. The bill also amends the Workforce Innovation and Opportunity Act and the Rehabilitation Act of 1973 to allow states to use federal funds for career and training services for such individuals, including career counseling, employee assistance programs, and educational resources for employers.